Save time and get answers to complex questions with AI chat
Drugpatentwatch market analysis industry today?Patent expiry trametinib?Mebendazole 100mg price?Guselkumab loss of exclusitivy?What is dabrafenib mesylate msn patent issue?
See the DrugPatentWatch profile for Breo
Breo Ellipta is a once-daily inhaler. It’s typically taken as one inhalation each day at the same time.
Patients generally use one dose per day (not two doses) unless their clinician specifically changes the plan.
Taking Breo Ellipta more frequently than directed can increase the risk of side effects from its components, particularly the fast-acting bronchodilator. Patients should follow the prescribed dose and dosing schedule on their prescription label.
Other Questions About Breo :